Literature DB >> 30627858

Short stature in advanced pediatric CKD is associated with faster time to reduced kidney function after transplant.

Yijun Li1, Larry A Greenbaum2, Bradley A Warady3, Susan L Furth4, Derek K Ng5.   

Abstract

BACKGROUND: Among children who receive a kidney transplant, short stature is associated with a more complicated post-transplant course and increased mortality. Short stature prior to transplant may reflect the accumulated risk of multiple factors during chronic kidney disease (CKD); however, its relationship with post-transplant kidney function has not been well characterized.
METHODS: In the Chronic Kidney Disease in Children (CKiD) cohort restricted to children who received a kidney transplant, short stature (i.e., growth failure) was defined as age-sex-specific height < 3rd percentile. The outcome was time to estimated glomerular filtration rate (eGFR) < 45 ml/min/1.73 m2 after transplant. Parametric survival models, including adjustment for disease severity, socioeconomic status (SES), and parental height by inverse probability weighting, described the relative times to eGFR< 45 ml/min/1.73 m2.
RESULTS: Of 138 children (median CKD duration at transplant: 13 years), 20% (28) had short stature before the transplant. The median time to eGFR < 45 ml/min/1.73 m2 after kidney transplantation was 6.6 years and those with short stature had a significantly faster time to the poor outcome (log-rank p value 0.004). Children with short stature tended to have lower SES, nephrotic proteinuria, higher blood pressure, and lower mid-parental height before transplant. After adjusting for these variables, children with growth failure had 40% shorter time to eGFR < 45 ml/min/1.73 m2 than those with normal stature (relative time 0.60, 95%CI 0.32, 1.03).
CONCLUSIONS: Short stature was associated with a faster time to low kidney function after transplant. SES, disease severity, and parental height partially explained the association. Clinicians should be aware of the implications of growth failure on the outcome of this unique population, while continued attempts are made to define modifiable factors that contribute to this association.

Entities:  

Keywords:  GFR; Graft loss; Growth failure; Kidney transplantation; Pediatrics

Mesh:

Year:  2019        PMID: 30627858      PMCID: PMC6424594          DOI: 10.1007/s00467-018-4165-2

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  32 in total

1.  The relationships between selected anthropometric and socio-economic data in schoolchildren from different social strata in Rio de Janeiro, Brazil.

Authors:  R Gross; F D de Lima; C J de Freitas; U Gross
Journal:  Rev Saude Publica       Date:  1990-02       Impact factor: 2.106

2.  Prevalence of complications in children with chronic kidney disease according to KDOQI.

Authors:  H Wong; K Mylrea; J Feber; A Drukker; G Filler
Journal:  Kidney Int       Date:  2006-06-21       Impact factor: 10.612

3.  Nutrition assessment of children with advanced stages of chronic kidney disease-A single center study.

Authors:  A Apostolou; N Printza; T Karagiozoglou-Lampoudi; J Dotis; F Papachristou
Journal:  Hippokratia       Date:  2014 Jul-Sep       Impact factor: 0.471

4.  Anthropometric measures and risk of death in children with end-stage renal disease.

Authors:  C S Wong; D S Gipson; D L Gillen; S Emerson; T Koepsell; D J Sherrard; S L Watkins; C Stehman-Breen
Journal:  Am J Kidney Dis       Date:  2000-10       Impact factor: 8.860

5.  Racial differences in renal replacement therapy initiation among children with a nonglomerular cause of chronic kidney disease.

Authors:  Derek K Ng; Marva Moxey-Mims; Bradley A Warady; Susan L Furth; Alvaro Muñoz
Journal:  Ann Epidemiol       Date:  2016-10-08       Impact factor: 3.797

6.  Pretransplant serum C-reactive protein and the risk of chronic allograft nephropathy in renal transplant recipients: a pilot case-control study.

Authors:  Jeffrey C Fink; Macaulay A Onuigbo; Steven A Blahut; Robert H Christenson; Dean Mann; Stephen T Bartlett; Matthew R Weir
Journal:  Am J Kidney Dis       Date:  2002-05       Impact factor: 8.860

7.  Growth failure, risk of hospitalization and death for children with end-stage renal disease.

Authors:  Susan L Furth; Wenke Hwang; Ching Yang; Alicia M Neu; Barbara A Fivush; Neil R Powe
Journal:  Pediatr Nephrol       Date:  2002-06       Impact factor: 3.714

8.  Evaluation of short and tall stature in children.

Authors:  Benjamin U Nwosu; Mary M Lee
Journal:  Am Fam Physician       Date:  2008-09-01       Impact factor: 3.292

Review 9.  Current advances in chronic kidney disease in children: growth, cardiovascular, and neurocognitive risk factors.

Authors:  Larry A Greenbaum; Bradley A Warady; Susan L Furth
Journal:  Semin Nephrol       Date:  2009-07       Impact factor: 5.299

Review 10.  Chronic kidney disease mineral and bone disorder in children.

Authors:  Katherine Wesseling; Sevcan Bakkaloglu; Isidro Salusky
Journal:  Pediatr Nephrol       Date:  2007-11-28       Impact factor: 3.714

View more
  4 in total

1.  Impact of Metabolic Acidosis and Alkali Therapy on Linear Growth in Children with Chronic Kidney Disease: What Is the Current Evidence?

Authors:  Emma H Ulrich; Rahul Chanchlani
Journal:  Kidney360       Date:  2022-03-09

Review 2.  Ultrasound-Based Renal Parenchymal Area and Kidney Function Decline in Infants With Congenital Anomalies of the Kidney and Urinary Tract.

Authors:  Bernarda Viteri; Mohamed Elsingergy; Jennifer Roem; Derek Ng; Bradley Warady; Susan Furth; Gregory Tasian
Journal:  Semin Nephrol       Date:  2021-09       Impact factor: 4.472

Review 3.  The CKiD study: overview and summary of findings related to kidney disease progression.

Authors:  Meredith A Atkinson; Derek K Ng; Bradley A Warady; Susan L Furth; Joseph T Flynn
Journal:  Pediatr Nephrol       Date:  2020-02-03       Impact factor: 3.714

Review 4.  Growth in children on kidney replacement therapy: a review of data from patient registries.

Authors:  Marjolein Bonthuis; Jérôme Harambat; Kitty J Jager; Enrico Vidal
Journal:  Pediatr Nephrol       Date:  2021-06-18       Impact factor: 3.714

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.